TWST Latest Press Releases

-- November 11, 2026 --

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Business Wire 8:00 AM

-- November 9, 2026 --

Twist Bioscience to Present at Upcoming Investor Conferences Business Wire 8:00 AM

-- November 4, 2026 --

Why the Next Edge in Antibody Discovery May Be What Labs Remember Globe Newswire 8:15 AM

-- November 3, 2026 --

Notice of Proposed Derivative Settlement: Twist Bioscience Corporation Business Wire 4:05 PM

-- October 29, 2026 --

Twist Bioscience Launches MRD Express with Rapid Turnaround Time Business Wire 8:00 AM

-- October 28, 2026 --

Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies Business Wire 8:00 AM

-- October 26, 2026 --

Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026 Business Wire 8:00 AM

-- September 16, 2026 --

Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery Business Wire 8:00 AM

-- September 9, 2026 --

Twist Bioscience to Present at Baird 2026 Global Healthcare Conference Business Wire 8:00 AM

-- August 4, 2026 --

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock Business Wire 11:45 PM

Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock Business Wire 4:01 PM

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Business Wire 8:00 AM

-- August 3, 2026 --

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results Business Wire 7:15 AM

-- July 15, 2026 --

Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026 Business Wire 8:00 AM

Market Data Delayed 15 Minutes